Jon Huntsman, Sr., said he was shocked by the unexpected firing of Mary Beckerle, CEO and director of the cancer center he founded and which his family continues to fund.
On Monday, April 17, Mary Beckerle opened her email and learned that she is no longer the CEO and director of the University of Utah's Huntsman Cancer Institute.
The American Society of Clinical Oncology said it opposes “right-to-try” laws that allow terminally ill patients to request access to investigational drugs directly from manufacturers, bypassing a layer of review, where FDA assesses the available data to review and benefits of the treatment on behalf of the patient.
Cancer patients in the U.S. paid nearly $4 billion in out-of-pocket costs in 2014 and the disease cost the country $87.8 billion in cancer-related health care spending, a report by the American Cancer Society Cancer Action Network found.
Scientific organizations should establish an advisory board that would have the overarching mandate to foster research integrity across disciplines.
Eleven cancer research ideas have received funding from Pelotonia, the annual cycling event that has raised more than $130 million for cancer research at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
This week, the USPSTF issued its draft guidelines for prostate cancer screening. They propose shifting from task force's recommendation against routine prostate cancer screening to a recommendation for informed and shared decision-making in which the physician and patient discuss the real risks of harm and the potential for life saving benefit before deciding on screening.
MD Anderson Cancer Center's complaint against Pelotonia, filed Oct. 5, 2016, argues that the Ohio cancer fundraiser's use of the slogan “One Goal: End Cancer” infringes on the Houston hospital's “One goal. Stop cancer.” registered trademark.
Every August, cyclists sign up for the Pelotonia ride that meanders through Ohio's rolling hills.
Former Vice President Joe Biden said he plans to launch the Biden Cancer Initiative, which would focus on data sharing, quality of cancer care, patient access, and increasing participation in clinical trials.
